Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation

doi:10.3748/wjg.v21.i2.533

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7896)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

409

WORD

188

HTML

3006

Figures (1-1)

239

Tables (1-4)

173

Sum=4015

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

574

Download

1024

Sum=1598

Publishing Process of This Article

Item

Count

Browse

955

Download

1328

Sum=2283

Jan 14, 2015 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jan 14, 2015; 21(2): 533-540
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.533

Table 2 Comparison of patient characteristics between the recombinant human soluble thrombomodulin and control groups

	rTM group(n = 30)	Control group (n = 36)	P value
Age (yr)	77.0 ± 7.7	75.7 ± 9.4	0.554
Sex (Male/Female)	22/8	21/15	0.203
Primary disease (Benign/Malignant)	21/9	21/15	0.327
Severity of cholangitis (Severe/Moderate)	28/2	32/4	0.845
DIC score	5.4 ± 1.4	5.2 ± 1.2	0.523
SIRS score	2.4 ± 1.3	2.6 ± 1.0	0.599
Biliary drainage	25	24	0.123
Anticoagulant drug
AT	26	16	< 0.001
GM	14	30	0.002
NM	4	18	0.004
DS	0	6	0.019
Antibiotics
MEPM	19	14	0.048
IPM/CS	0	7	0.031
DRPM	5	0	0.037
SBT/CPZ	5	14	0.047
TAZ/PIPC	1	1	0.556

DIC: Disseminated intravascular coagulation; SIRS: Systemic inflammatory response syndrome; rTM: Recombinant human soluble thrombomodulin; AT: Antithrombin; GM: Gabexate mesilate; NM: Nafamostat mesilate; DS: Danaparoid sodium; MEPN: Meropenem; IPM/CS: Imipenem/Cilastatin; DRPM: Doripenem; SBT/CPZ: Sulbactam/Cefoperazone; TAZ/PIPC: Tazobactam/Piperacilin.

Citation: Suetani K, Okuse C, Nakahara K, Michikawa Y, Noguchi Y, Suzuki M, Morita R, Sato N, Kato M, Itoh F. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation. World J Gastroenterol 2015; 21(2): 533-540
URL: https://www.wjgnet.com/1007-9327/full/v21/i2/533.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i2.533